Predisposition to Efficient Mammary Tumor Metastatic Progression Is Linked to the Breast Cancer Metastasis Suppressor Gene Brms1

Kent W. Hunter; Karl W. Broman; Thomas Le Voyer; Luanne Lukes; Diana Cozma; Michael T. Debies; Jessica Rouse; Danny R. Welch

Predisposition to Efficient Mammary Tumor Metastatic Progression Is Linked to the Breast Cancer Metastasis Suppressor Gene Brms1

Kent W. Hunter
, Karl W. Broman
, Thomas Le Voyer
, Luanne Lukes
, Diana Cozma
, Michael T. Debies
, Jessica Rouse
, Danny R. Welch

Laboratory of Population Genetics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA.

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Cancer Research
Volume	61
Issue number	24
State	Published - Dec 15 2001

Disciplines

Immunology and Infectious Disease
Biology
Oncology

Cite this

@article{c5b803c58fad47fc836b0349f67511ba,

title = "Predisposition to Efficient Mammary Tumor Metastatic Progression Is Linked to the Breast Cancer Metastasis Suppressor Gene Brms1",

author = "Hunter, \{Kent W.\} and Broman, \{Karl W.\} and \{Le Voyer\}, Thomas and Luanne Lukes and Diana Cozma and Debies, \{Michael T.\} and Jessica Rouse and Welch, \{Danny R.\}",

note = "Tumor metastasis is one of the most important clinical aspects of neoplastic disease because patient mortality is frequently attributable to disseminated rather than primary tumors. However, it still is not possible to definitively distinguish those individuals at high risk for disseminated disease, who would benefit from aggressive adjuvant therapy, from the low-risk patients who might be spared the side effects of additional anticancer therapy.",

year = "2001",

month = dec,

day = "15",

language = "American English",

volume = "61",

journal = "Cancer Research",

issn = "1538-7445",

publisher = "American Association for Cancer Research",

number = "24",

}

TY - JOUR

T1 - Predisposition to Efficient Mammary Tumor Metastatic Progression Is Linked to the Breast Cancer Metastasis Suppressor Gene Brms1

AU - Hunter, Kent W.

AU - Broman, Karl W.

AU - Le Voyer, Thomas

AU - Lukes, Luanne

AU - Cozma, Diana

AU - Debies, Michael T.

AU - Rouse, Jessica

AU - Welch, Danny R.

N1 - Tumor metastasis is one of the most important clinical aspects of neoplastic disease because patient mortality is frequently attributable to disseminated rather than primary tumors. However, it still is not possible to definitively distinguish those individuals at high risk for disseminated disease, who would benefit from aggressive adjuvant therapy, from the low-risk patients who might be spared the side effects of additional anticancer therapy.

PY - 2001/12/15

Y1 - 2001/12/15

UR - https://cancerres.aacrjournals.org/content/61/24/8866

M3 - Article

SN - 1538-7445

VL - 61

JO - Cancer Research

JF - Cancer Research

IS - 24

ER -

Predisposition to Efficient Mammary Tumor Metastatic Progression Is Linked to the Breast Cancer Metastasis Suppressor Gene Brms1

Disciplines

Other files and links

Cite this